Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mark Spengler"'
Autor:
Olivia Bonduelle, Andrew Naylor, Toon Stegmann, Charli Smardon, Mario Amacker, Markus Schwaller, Richard Alan Johnson, Desmond Wong, Mark Spengler, Michael Adler, Olga Belova, Béhazine Combadière, Jack Sorrell, Sylvain Fleury, Beena Punnamoottil, Laura M. Mason, Kirk Jeffery, Farien Bhoelan
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 5, Iss 1, Pp 1-16 (2020)
npj Vaccines, Vol 5, Iss 1, Pp 1-16 (2020)
The main objective of the MACIVIVA European consortium was to develop new Good Manufacturing Practice pilot lines for manufacturing thermostable vaccines with stabilized antigens on influenza virosomes as enveloped virus-like particles. The HIV-1 gp4
Publikováno v:
Biochemical and Biophysical Research Communications. 488:311-315
Immuno-PCR (IPCR) combines the versatile ELISA antigen detection with ultrasensitive PCR signal amplification, thereby enabling the highly sensitive detection of a broad range of targets with a typically very large dynamic detection range. The quanti
Autor:
Michael Adler, Mark Spengler, Andreas Jonas, Beena Punnamoottil, Christian Pieper, Nina Juergens
Publikováno v:
Frontiers in Pharmacology. 8
Publikováno v:
Frontiers in Pharmacology. 8
Publikováno v:
Frontiers in Pharmacology. 8
Autor:
Alvydas Mikulskis, Mark Spengler, Yao Zhuang, Alison Joyce, Saloumeh K Fischer, Tong-Yuan Yang, Marianne Scheel Fjording
Publikováno v:
The AAPS Journal. 17:93-101
Ligand binding assays (LBAs) have been the method of choice for protein analyte measurements for more than four decades. Over the years, LBA methods have improved in sensitivity and achieved larger dynamic ranges by using alternative detection system
Publikováno v:
Advanced Functional Materials. 17:437-442
DNA oligonucleotides are extraordinarily well suited as linkers for the programmable assembly of nanoparticles. To extend the scope of DNA-directed particle assembly, a 70 nm DNA linker molecule for the DNA-directed assembly of gold nanoparticles is
Publikováno v:
Analyst, 140 (18), 6175-6194
Recombinant DNA technology and corresponding innovations in molecular biology, chemistry and medicine have led to novel therapeutic biomacromolecules as lead candidates in the pharmaceutical drug development pipelines. While monoclonal antibodies and
Publikováno v:
Biochemical and biophysical research communications. 387(2)
The administration of therapeutic proteins often induces immunogenic response and thus formation of anti-drug antibodies (ADA), which can neutralize the drug's therapeutic effect and may even cause serious health problems. We here report on the emplo
Autor:
Mark Spengler, Heiko Hayen, Christof M. Niemeyer, Valerie J. Gandubert, Kersten S. Rabe, Michael Erkelenz, Joachim Müller
Publikováno v:
Chembiochem : a European journal of chemical biology. 10(4)
Cytochrome P450 enzymes are known to catalyze a variety of reactions that are difficult to perform by standard organic synthesis, such as the oxidation of unactivated C--C bonds. Cytochrome P450 enzymes can also be used in artificial systems in which